SCHEMBL25869733

SCHEMBL25869733

CCCCCCCCCCCCOCC(CC)OCCCCCCCC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LPAR1 Q92633 7/20 0.59
▸ LPAR3 Q9UBY5 7/20 0.59
▸ LPAR2 Q9HBW0 4/20 0.59
▸ DNM1 Q05193 1/20 0.55
▸ USP2 O75604 1/20 0.52
▸ TLR2 O60603 6/20 0.50
▸ HTT P42858 1/20 0.50
▸ PRKD3 O94806 1/20 0.49
▸ PRKCG P05129 1/20 0.49
▸ PRKCB P05771 1/20 0.49
▸ PRKCA P17252 1/20 0.49
▸ PRKCH P24723 1/20 0.49
▸ PRKCI P41743 1/20 0.49
▸ PRKCE Q02156 1/20 0.49
▸ PRKCQ Q04759 1/20 0.49
▸ PRKCZ Q05513 1/20 0.49
▸ PRKCD Q05655 1/20 0.49
▸ PRKD1 Q15139 1/20 0.49
▸ LPAR6 P43657 3/20 0.47
▸ LPAR4 Q99677 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10133121 1.00 LPAR1 (0.59) LPAR1LPAR3LPAR2DNM1USP2
SCHEMBL25869722 1.00 LPAR1 (0.59) LPAR1LPAR3LPAR2DNM1USP2
SCHEMBL17447015 1.00 LPAR1 (0.59) LPAR1LPAR3LPAR2DNM1USP2
SCHEMBL14818813 1.00 LPAR1 (0.59) LPAR1LPAR3LPAR2DNM1USP2
SCHEMBL19075317 1.00 LPAR1 (0.59) LPAR1LPAR3LPAR2DNM1USP2
SCHEMBL12648546 1.00 LPAR1 (0.59) LPAR1LPAR3LPAR2DNM1USP2
SCHEMBL8406084 1.00 LPAR1 (0.59) LPAR1LPAR3LPAR2DNM1USP2
SCHEMBL8406194 1.00 LPAR1 (0.59) LPAR1LPAR3LPAR2DNM1USP2
SCHEMBL12990768 1.00 LPAR1 (0.59) LPAR1LPAR3LPAR2DNM1USP2
SCHEMBL18512649 0.98 LPAR1 (0.57) LPAR1LPAR3LPAR2DNM1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230233468-A1 LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS Suzhou Abogen Biosciences Co., Ltd. (CN) 2023-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230233468-A1 LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS CETP, NPC1, LCAT LPAR1 191/4885LPAR3 201/4885LPAR2 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback